Imagine an IVF laboratory where thousands of embryo images can be analyzed by a computer in seconds. The system can identify patterns that may be difficult for the human eye to notice and help embryologists compare embryos more consistently.
This is no longer just a futuristic idea. Artificial intelligence (AI) is increasingly being studied and used in embryology, particularly for embryo assessment and selection. But an important question remains: Can AI really identify the “best” embryo for pregnancy?
The answer is more nuanced than a simple yes or no.
What Is AI in Embryology?
AI in embryology refers to computer systems that learn from large amounts of data and use that information to identify patterns.
In IVF laboratories, AI can analyze:
- Still images of embryos
- Time-lapse images or videos
- Embryo development patterns
- Morphological features
- Timing of cell divisions
- Other laboratory and clinical data
Some AI systems are designed to rank embryos according to predicted developmental potential or other outcomes.
The goal is not necessarily to replace the embryologist. Instead, AI may provide additional information to support embryo assessment and decision-making. ASRM’s recent guidance describes AI as a potentially valuable adjunct in IVF laboratories but emphasizes the need for proper validation before relying on it clinically.
How Are Embryos Traditionally Selected?
Embryologists have traditionally assessed embryos by looking at their appearance under a microscope.
They may examine factors such as:
- Cell number and symmetry
- Degree of fragmentation
- Developmental stage
- Blastocyst expansion
- Inner cell mass
- Trophectoderm appearance
This process is known as embryo morphology assessment.
It is an important part of IVF, but visual grading involves professional judgment. Different embryologists may sometimes grade or rank the same embryos differently.
AI is being investigated partly because it may help make this assessment more consistent. ASRM notes that AI-based systems have shown promise in embryo grading, although further validation is needed.
How Does AI Help With Embryo Selection?
AI can process large amounts of image data much faster than a person.
A simplified process looks like this: Embryo → Image/Time-lapse data → AI analysis → Pattern recognition → Embryo ranking or prediction → Embryologist’s clinical decision
With time-lapse imaging, an embryo can be photographed at regular intervals while it develops inside a specialized incubator. This creates a detailed record of its development.
AI can then analyze changes over time, including the timing and pattern of cell divisions. This may provide information that is difficult to capture through occasional microscopic observations. ESHRE has separate good-practice recommendations addressing the use of time-lapse technology in IVF laboratories.
Can AI Predict Which Embryo Will Implant?
This is where expectations need to be realistic. Researchers have developed AI models that attempt to predict outcomes such as:
- Blastocyst development
- Embryo implantation potential
- Pregnancy-related outcomes
- Chromosomal status in some research settings
- Relative ranking of embryos for transfer
However, prediction is not the same as certainty. An embryo’s development and pregnancy outcome depend on many biological factors. An AI system analyses the information available to it, but it cannot see every factor that determines whether an embryo will implant and develop into a healthy baby.
ASRM’s 2024 guidance on PGT-A also notes that AI and other technologies are being investigated as additional approaches to embryo selection, alongside established methods such as morphology assessment and genetic testing.
AI Does Not Replace Genetic Testing
This is an important distinction for IVF patients. AI-based embryo selection and pre-implantation genetic testing (PGT) is not the same thing.
AI may analyze images or developmental patterns. PGT involves laboratory testing of genetic material from an embryo biopsy for specific purposes. Therefore, an AI system looking at an embryo image cannot simply be described as “checking the embryo’s chromosomes.”
ASRM considers PGT-A separately from morphology-based and AI-assisted approaches to embryo selection.
What Are the Advantages of AI in Embryology?
Potential benefits include:
- More consistent assessment
AI may help reduce some variation in embryo grading between observers.
- Analysis of large amounts of information
Computers can process thousands of images and developmental data points rapidly.
- Time-lapse analysis
AI can examine the complete developmental sequence rather than relying only on selected observations.
- Decision support
AI may provide an additional source of information for embryologists when several embryos appear suitable for transfer.
- Improved laboratory workflow
Recent ASRM guidance notes that AI-assisted evaluation may substantially reduce the time required for some embryo assessment tasks.
What Are the Limitations?
AI is powerful, but it is not infallible. Some important concerns include:
- AI models may perform differently in different IVF laboratories.
- Training data may not represent every patient population.
- Different imaging systems and laboratory conditions can affect performance.
- A prediction may be statistically useful without guaranteeing an individual patient’s outcome.
- Many studies have been retrospective rather than large prospective clinical trials.
- The clinical benefit of using AI still needs stronger real-world evidence.
ASRM’s 2026 committee opinion specifically highlights the need for rigorous evaluation and validation of AI systems before widespread clinical reliance.
So, Can AI Select the Best Embryo?
AI can help identify and rank embryos based on patterns associated with better predicted outcomes. But it cannot currently guarantee which embryo will produce a healthy live birth.
Think of AI as an additional analytical tool rather than an independent decision-maker.
The embryologist still plays an important role in interpreting the findings alongside embryo morphology, laboratory conditions, patient history, and other relevant clinical information.
This human-and-AI combination may ultimately be more useful than expecting either technology or human judgement to work alone.
What Should IVF Patients Ask Their Clinic?
If your clinic offers AI-assisted embryo selection, consider asking:
- What AI technology is being used?
- What outcome has the system actually been validated to predict?
- Has it been evaluated in clinical practice or mainly in research datasets?
- Does the clinic use AI alongside standard embryologist assessment?
- Is time-lapse imaging involved?
- How will the AI result affect the embryo-transfer decision?
- Are there additional costs for AI-assisted assessment?
These questions can help patients understand what the technology can—and cannot—tell them.
The Future of AI in Embryology
AI is developing rapidly in reproductive medicine. Current research is moving beyond simply grading embryo appearance toward analyzing developmental patterns, time-lapse videos, and multiple sources of clinical information.
At the same time, professional organizations are emphasizing responsible implementation, validation, patient safety, and realistic communication about what AI can achieve. ESHRE’s 2026 IVF laboratory guidance continues to place strong emphasis on quality, standardization, embryo culture, embryo transfer and laboratory safety.
The future may therefore not be about “AI choosing the embryo.” It may be about AI helping embryologists make better-informed decisions from more information than the human eye can easily process.
Final Takeaway
AI in embryology is an exciting development in modern IVF, but it is not a crystal ball. Artificial intelligence can analyze embryo images, recognize developmental patterns, and potentially help embryologists rank embryos more consistently. However, a high AI score does not guarantee implantation, pregnancy, or the birth of a healthy baby.
For patients, the most important question is not simply whether a clinic uses AI. It is how the technology has been validated, what information it provides, and how experienced embryologists and fertility specialists use that information as part of the overall IVF decision-making process. As research continues, AI may become an increasingly useful partner in the embryology laboratory while clinical expertise and patient-centered care remain essential.
Ravi Sharma is a self-motivated, successful entrepreneur and has a solid experience in the fertility segment. and he is the director at ARTbaby Global (ARThealthcare). He is a pharmacy graduate with post-graduation in business administration and has 14 years of rich experience in the field of infertility segment. He loves to write about IVF, Surrogacy, and other ART (assisted reproductive technology) news, issues, and updates. He is a Pharmacy graduate (B. Pharm) and M.B.A (marketing).
His most recent success includes the successful launch of the medical tourism company, ARTbaby, which offers treatment options for infertility, egg donation, and surrogacy. He likes spending time with his family and writing about various aspects of IVF surrogacy and donating eggs.